Kohei Shitara, MD

Videos

Perioperative Pembrolizumab Plus Chemotherapy for Resectable Gastric or Gastroesophageal Junction Cancer

11/14/2023

In the KEYNOTE-585 study, perioperative pembrolizumab plus chemotherapy improved the pathological complete response among patients with locally advanced, resectable gastric or gastroesophageal (G/GEJ) cancer, but not the event-free survival.

In the KEYNOTE-585 study,...

11/14/2023

Oncology

Relative impact of T4 and N2 on the efficacy of 3 versus 6 months of adjuvant CAPOX for high-risk stage II and stage III colon cancer: ACHIEVE and ACHIEVE-2 trials

Background Results in the IDEA Collaboration have allowed clinical practice guidelines to prioritise 3-months (3m) of CAPOX for the ad...

Takeharu Yamanaka ;

Y. Maehara ;

M. Kotaka ;

M. Mori ;

D. Manaka ;

M. Shiozawa ;

Y. Sakamoto ;

Y. Munemoto ;

T. Eto ;

Kohei Shitara , MD;

A. Shiomi ;

J. Hasegawa ;

A. Makiyama ;

A. Takagane ;

Takayuki Yoshino , MD, PhD;

Eiji Oki ;

T. Kato ;

T. Mizushima ;

M. Nakamura ;

E. Sunami ;

K. Yamazaki ;

A. Ohtsu ;

06/30/2020

Emerging Concepts in HER2-Driven Gastrointestinal Cancers

Kohei Shitara , MD;

Josep Tabernero , MD, PhD;

Salvatore Siena , MD;

Eric Van Cutsem , MD, PhD;

08/16/2019

New Targets and Agents in Upper GI Cancer

Kohei Shitara , MD;

07/06/2023

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Kohei Shitara, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products